[Role of second-generation antipsychotics in the treatment of affective disorders -- review of the literature and future perspectives].
This article reviews the role of the second generation antipsychotics in the treatment of  affective disorders. The treatment of major depressive disorders and the acute and long-term treatment of bipolar affective disorders are also discussed. After the special role of quetiapine is highlighted, a novel psychopharmacological terminology and nomenclature are also introduced.
Pszichiátriai és Pszichoterápiás Klinika, Pécsi Tudományegyetem, Pécs, Hungary. viktor.voros@aok.pte.hu
Viktor
V
Vörös
D018687:Antidepressive Agents, Second-Generation / Q000494:pharmacology / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000523:psychology; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D003987:Dibenzothiazepines / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D019964:Mood Disorders / Q000188:drug therapy* / Q000523:psychology; D011600:Psychopharmacology; D000069348:Quetiapine Fumarate; D016032:Randomized Controlled Trials as Topic
D018687:Antidepressive Agents, Second-Generation; D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D000069348:Quetiapine Fumarate